BabyBIG
STN: 125034
Proper Name: Botulism Immune Globulin Intravenous (Human)
Tradename: BabyBIG
Manufacturer: California Department of Public Health (CDPH)
Indication:
- Treatment of infant botulism caused by toxin types A or B in patients below one year of age.
Product Information
Supporting Documents
- June 23, 2021 Approval Letter - BabyBIG
- March 29, 2016 Approval Letter - BabyBIG
- Supporting Documents older than three years - BabyBIG
Related Information
- Dear Healthcare Provider Letter: IMPORTANT CHANGE IN BabyBIG PRESCRIBING INFORMATION - ARCHIVED
Date: September 23, 2013